SGS launches new large molecule bioanalytical services

Investment builds on company's expertise in small molecule analysis and the use of LC/MS-MS techniques.

The investment includes the installation of Sciex instruments, and the introduction of supporting Sciex BioBA sample preparation kits. This will allow the laboratory to handle the analysis of a wide range of samples, including peptides, proteins and complex biological molecules, such as monoclonal antibodies. Initially, the service will focus on pre-clinical samples, with the aim of rapidly expanding this to analytical methods used for clinical studies.

Bernard Jeanbaptiste, Bioanalysis Manager for SGS Belgium, said: “Our laboratory at Wavre has a rich history and expertise in small molecule analysis and the use of LC/MS-MS techniques. As a result, this investment is a natural progression of our capabilities, enabling us to serve the growing market for large molecule analysis and characterization. The investment will bring value to clients and support our current activities in large molecule bioanalysis across the global SGS network.”

SGS’s Wavre 8,400 m2 laboratory, on the outskirts of Brussels, provides a wide range of services to clients around the world, including method development and validation, analytical chemistry, microbiological testing, potency assays and cell line characterization.